SNAP Stays Afloat Amid Shutdown Crisis

The Daily Brief — November 3, 2025

A concise, nonpartisan roundup of what genuinely moved in the last 24 hours across the U.S., the world, science, technology, and business.


US News

  • Courts press USDA to keep SNAP flowing during shutdown

    • Two federal judges ordered the administration to use contingency funds to continue Supplemental Nutrition Assistance Program payments despite the funding lapse; USDA must report compliance plans, though timing and amounts may vary by state. (reuters.com)
    • States have warned of delays; North Carolina’s health department said November benefits would be off-schedule absent federal funds. (ncdhhs.gov)
  • Air travel disruptions widening

    • FAA staffing shortfalls tied to unpaid controllers have triggered recurring ground stops and extended waits at several major airports, with officials warning of worse delays if the shutdown persists. (investing.com)
  • Political stance unchanged

    • President Trump reiterated he won’t negotiate until Democrats vote to reopen the government, keeping the shutdown in week six. (apnews.com)

Why it matters (Munger lens): policy risk is directly impinging on real-economy throughput (air travel) and low‑income consumption (SNAP), two inputs to near‑term earnings quality in staples, airlines, airports, and grocers.


Global News

  • OPEC+ pauses planned Q1 2026 hikes; oil edges up

    • The alliance kept a modest December +137k bpd increase but suspended further hikes in Q1 on surplus risks; Brent hovered near $65 and WTI near $61. (reuters.com)
    • Banks are revising forward curves: Morgan Stanley lifted its H1 2026 Brent forecast to $60, citing the pause and new U.S./EU sanctions on Russian oil firms. (reuters.com)
  • Ukraine strikes Russian Black Sea oil infrastructure

    • Drones ignited fires at Tuapse’s oil terminal; at least one vessel was damaged, according to regional reports and Ukrainian sources. Market implications include incremental logistics risk for Russian product exports. (spokesman.com)

Why it matters: supply management plus infrastructure risk keeps a volatility floor under energy, even as surplus fears persist—important for transport, chemicals, and margins across energy‑intensive industries.


Science

  • FDA surprise for Huntington’s gene therapy

    • The FDA told uniQure that Phase I/II data for AMT‑130 are inadequate for a U.S. filing now, sending shares sharply lower and resetting timelines in a high‑profile neurodegenerative program. (reuters.com)
  • New data on interstellar comet 3I/ATLAS

    • JWST-linked analyses suggest a radiation‑altered outer crust that could mask primordial composition; spacecraft flybys this week remain the best shot at fresh material. (livescience.com)

Why it matters: for biopharma, regulatory “goal‑post” shifts are a reminder to anchor on probability‑weighted outcomes; for space science, rare interstellar samples can reshuffle formation models—small odds, high insight.


Technology

  • US tightens rhetoric on top AI chips

    • President Trump signaled Nvidia’s most advanced Blackwell chips should stay in the U.S., reinforcing an already‑restrictive export posture. Expect continued tension around “de‑rated” export SKUs. (reuters.com)
  • OpenAI–Microsoft tie-up remains in focus

    • Media reports last week highlighted a restructured OpenAI governance/finance setup alongside a renewed long‑term pact with Microsoft; stakes and terms remain a moving target and bear watching for hyperscaler–model provider economics. (windowscentral.com)

Why it matters: compute chokepoints and policy risk are dictating who captures AI economics—chip vendors, hyperscalers, or applications—shaping capex cycles and margins.


Business & Markets

  • Oil and energy equities: cautious bid

    • Crude firmed modestly after OPEC+ signaled a Q1 pause; analysts framed the move as pre‑empting surplus risk amid record U.S. output. (reuters.com)
  • Earnings watch: AI bellwethers on deck

    • Palantir reports after the bell today (Nov 3); options imply a double‑digit move, with focus on U.S. commercial growth and AIP uptake. Qualcomm follows Wednesday (Nov 5). (tipranks.com)
  • Notable single‑name move

    • uniQure’s pre‑market collapse on FDA feedback (above) underscores binary risk in small/mid‑cap biotech and potential spillover into gene therapy sentiment. (reuters.com)

Why it matters: near‑term leadership remains tied to AI monetization proof points and energy discipline, while regulatory turns can create acute dispersion in healthcare.


What might interest a Munger‑style investor

  1. Policy uncertainty is a tangible cost: the shutdown’s SNAP rulings and FAA disruptions show how legal and operational frictions translate into consumption and throughput risk; look for knock‑ons in grocery comps, airline CASM/RASM, and airport retailers. (reuters.com)

  2. Energy’s “managed surplus”: OPEC+ is trying to pre‑empt glut dynamics without ceding share; forward curves and sanctions flow‑through argue for selectivity—own low‑cost, balance‑sheet‑disciplined producers and midstream with resilient volumes. (reuters.com)

  3. Compute geopolitics sets margins: export lines around Blackwell‑class chips and hyperscaler–model partnerships will determine where value accrues across the stack; prefer businesses with differentiated moats beyond pure hardware availability. (reuters.com)


Key dates

Sources are linked inline.